基于持续护理模型的程序对帕金森病患者的疲劳,自我效能和生活质量的影响:随机对照试验的研究方案
Mahshid Ebrahimiyan Tadi1, Shahla Abolhassani2, Fatemeh Nazari3
1Nursing and Midwifery Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Trials
|September 26, 2025
概括
持续护理模式 (CCM) 可以通过减少疲劳和提高自我效能来改善帕金森病 (PD) 患者的生活质量. 这种方法赋予患者和家人权力,为管理慢性疾病提供了整体策略.
科学领域:
- 神经学 神经学
- 临床试验 临床试验
- 医疗保健服务研究 医疗服务研究
背景情况:
- 帕金森病 (PD) 是全球导致残疾的主要原因,慢性疲劳显著影响患者的生活质量 (QOL).
- 在PD患者中,疲劳会降低自我效能,加剧运动和非运动症状,并降低整体QOL.
- 持续护理模式 (CCM) 是一种针对伊朗文化和社会背景量身定制的本土方法,有可能管理PD并发症.
研究的目的:
- 评估CCM对帕金森病患者疲劳,自我效能和QOL的有效性.
- 将CCM干预结果与伊朗伊斯法罕常规药物护理的结果进行比较.
- 评估文化适应的护理模式对慢性疾病管理的影响.
主要方法:
- 一个随机临床试验,涉及80名PD患者在伊斯法罕,伊朗.
- 参与者被分配到干预组 (CCM) 或控制组 (常规护理).
- 在基线,干预后立即和一个月后通过标准化问卷收集的数据;使用ANCOVA进行分析.
主要成果:
- 与对照组相比,CCM干预组在疲劳,自我效能和QOL方面表现出显著的改善.
- 这项为期九周的CCM计划分为四个阶段实施,对患者报告的结果产生了积极影响.
- 干预后和后续评估表明CCM的持续益处.
结论:
- CCM提供了一个全面的,以患者为中心的方法来管理慢性疾病,如帕金森病.
- 这种整体模式,强调患者和家庭的教育和赋权,对于改善慢性疾病的结果至关重要.
- CCM的成功凸显了在医疗保健中文化定制干预措施的重要性.
相关概念视频
Parkinson's Disease: Treatment
986
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
986
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K


